Biotechnology workshop of the Silesian Park of Technology Kardio-Med Silesia with Celon Pharma – the market leader of innovative pharmaceutical companies in Poland!

A biotechnology workshop of representatives of the Silesian Park of Medical Technology Kardio-Med Silesia with the company Celon Pharma S.A. was held on 06.12.2022. Celon Parma S.A. is an innovative pharmaceutical company that conducts advanced scientific research and produces modern drugs. The workshop on the part of the Silesian Park of Medical Technology Kardio-Med.

Silesia was attended by:

• Adam Konka – Chairman of the Silesian Park of Medical Technology Kardio-Med Silesia
• Ewa Malada – Manager of Lab. Test and Implementation Lab of New Technologies and Medical Devices
• Marzena Dyhdalewicz – GLP/GMP Specialist
• Dominika Korner – Research Group Leader of the project “Personalized liposome-based small inhibitory RNA therapy for acute myeloid leukemia (OBS/AML)”

We would like to thank for organizing this workshop at the headquarters of Celon Pharma S.A. Mr. President Dr. Maciej Wieczorek. We hope that this workshop will result in the establishment of a lasting research collaboration between Celon Pharma S.A. and the Silesian Park of Medical Technology Kardio-Med Silesia.